Quantitative Tear MMP-9 Test

About Axim Biotech

AXIM Biotechnologies is a diagnostic-focused R&D company with a mission to improve patient lives through rapid, in-clinic testing solutions. The company has achieved commercial validation with two FDA-cleared ophthalmological diagnostics and is leveraging its integrated platform to diversify into early cancer detection and cannabinoid research. Its strategy combines direct commercialization, strategic alliances, and a client-focused diagnostic development service to address unmet needs in multiple therapeutic areas.

Therapeutic Areas